V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 230001722 | 230000931 | 1.81 | null | null | 2018-07-27 | 2018-07-27 | Sorafenib | N | N | 230011482 | GEMCITABINE |
| 230001723 | 230000970 | null | 74.8 | Palliative (P) | 2017-12-21 | 2017-12-21 | Capecitabine | 2 | Y | 230015009 | TRASTUZUMAB |
| 230001724 | 230001419 | 1.67 | 92 | Palliative (P) | 2018-07-09 | 2018-07-13 | CAPECITABINE + OXALIPLATIN | 02 | N | 230020468 | BCG |
| 230001725 | 230001002 | 1.69 | 74.8 | Curative (C) | 2018-02-04 | 2018-09-24 | BEVACIZUMAB + CARBO + PACLITAXEL | 02 | N | 230023578 | ABIRATERONE |
| 230001726 | 230001014 | 1.55 | null | Neo-adjuvant (N) | 2018-11-04 | 2018-11-04 | null | 2 | N | 230025262 | ENZALUTAMIDE |
| 230001727 | 230001427 | 1.67 | 94 | Palliative (P) | 2018-11-09 | 2018-11-27 | Oxaliplatin + Modified de Gramont | N | N | 230025405 | VANDETANIB |
| 230001728 | 230001025 | 1.64 | 67 | Neo-adjuvant (N) | 2016-07-26 | 2016-07-26 | GEMCITABINE | 02 | N | 230027082 | RITUXIMAB |
| 230001729 | 230001046 | null | 89.2 | Palliative (P) | 2019-09-18 | 2019-10-15 | Capecitabine 35days + RT | N | N | 230012425 | CISPLATIN + RT |
| 230001730 | 230001303 | 1.55 | null | Palliative (P) | 2017-04-10 | 2017-04-10 | FLUOROURACIL + IRINOTECAN | N | N | 230021348 | CAPECITABINE + OXALIPLATIN |
| 230001731 | 230000685 | 1.62 | 62 | Palliative (P) | 2014-02-13 | 2014-07-03 | Paclitaxel 80mg/m2 day 1 8 15 | N | N | 230023028 | CAPECITABINE + IRINOTECAN |
| 230001732 | 230001312 | 1.63 | null | Palliative (P) | 2018-11-02 | 2018-12-01 | Oxaliplatin + Modified de Gramont | N | N | 230024143 | OXALIPLATIN + MDG |
| 230001733 | 230000720 | 1.64 | 69.05 | Palliative (P) | 2015-07-17 | 2015-07-31 | CETUXIMAB + IRINOTECAN + MDG | N | N | 230026784 | IRINOTECAN + MDG |
| 230001734 | 230000720 | 1.6 | 57.6 | Adjuvant (A) | 2015-12-29 | 2016-01-27 | Capecitabine + Oxaliplatin 21day | N | N | 230026784 | CAPECITABINE |
| 230001735 | 230000732 | 1.81 | 90 | Palliative (P) | 2016-09-07 | 2016-09-08 | Oxaliplatin + Modified de Gramont | N | N | 230000436 | CETUXIMAB + IRINOTECAN + MDG |
| 230001736 | 230000820 | 1.74 | 54.4 | Neo-adjuvant (N) | 2020-01-01 | 2020-07-05 | TRASTUZUMAB | N | N | 230003846 | OXALIPLATIN + MDG |
| 230001737 | 230000855 | 1.61 | 63.4 | Palliative (P) | 2018-12-22 | 2018-12-23 | AFLIBERCEPT + FU + IRINOTECAN | N | N | 230005457 | GEMCARBO |
| 230001738 | 230000875 | 1.81 | null | null | 2017-09-07 | 2017-10-09 | CHOP R - 21 days | 02 | N | 230007118 | CAPECITABINE + OXALIPLATIN |
| 230001739 | 230000888 | 1.53 | 56.6 | Palliative (P) | 2019-10-14 | 2019-10-15 | CARBOPLATIN + ETOPOSIDE | 2 | N | 230007554 | VANDETANIB |
| 230001740 | 230000901 | 1.8 | 80.9 | Palliative (P) | 2017-11-29 | 2017-12-26 | LENVATINIB | 02 | N | 230008316 | OXALIPLATIN + MDG |
| 230001741 | 230001694 | 1.8 | 76.5 | Not known (9) | 2018-11-27 | 2018-12-05 | Oxaliplatin + Modified de Gramont | N | N | 230011482 | CHOP R |
| 230001742 | 230001003 | 1.63 | 73 | Curative (C) | 2018-03-03 | 2018-09-09 | Rituximab (Maintenance) | 02 | N | 230023578 | NOT MATCHED |
| 230001743 | 230001017 | 1.79 | 73 | Palliative (P) | 2019-01-19 | 2019-02-05 | Capecitabine | N | N | 230025405 | BENDAMUSTINE + RITUXIMAB |
| 230001744 | 230001026 | 1.54 | 101 | Neo-adjuvant (N) | 2015-09-11 | 2016-10-12 | GEMCITABINE | 02 | N | 230027082 | ETOPOSIDE |
| 230001745 | 230001047 | null | 126.8 | Palliative (P) | 2019-12-24 | 2020-01-01 | Irinotecan + Modified De Gramont | N | N | 230012425 | CARBOPLATIN + ETOPOSIDE |
| 230001746 | 230000667 | 1.59 | 63.4 | Palliative (P) | 2018-04-30 | 2018-06-10 | Methotrexate High Dose (3g/m2) | N | N | 230021348 | AFLIBERCEPT + FU + IRINOTECAN |
| 230001747 | 230000685 | 1.57 | 68 | Palliative (P) | 2017-04-01 | 2017-09-22 | Capecitabine (14 day) + Irinotecan | N | N | 230023028 | OXALIPLATIN + MDG |
| 230001748 | 230000690 | 1.58 | 56.2 | Palliative (P) | 2018-11-12 | 2018-12-01 | Fluorouracil + Folinic Acid Weekly | N | N | 230024143 | IRINOTECAN + MDG |
| 230001749 | 230000901 | 1.77 | 78.8 | Palliative (P) | 2018-08-24 | 2018-08-29 | Bevacizumab | 02 | N | 230008316 | IRINOTECAN + MDG |
| 230001750 | 230001727 | 1.84 | 122 | Disease modification (D) | 2018-11-28 | 2018-12-05 | Trifluridine + Tipiracil | N | N | 230011482 | TRASTUZUMAB |
| 230001751 | 230000690 | 1.73 | 59 | Palliative (P) | 2018-11-01 | 2018-12-01 | CETUXIMAB + MDG | N | N | 230024143 | CAPECITABINE + OXALIPLATIN |
| 230001752 | 230000691 | 1.59 | 89 | Palliative (P) | 2019-05-12 | 2019-06-07 | Capecitabine + Oxaliplatin 21day | N | N | 230024143 | CAPECITABINE + OXALIPLATIN |
| 240000001 | 240000001 | 1.6 | 59.2 | Curative (C) | 2018-02-05 | 2018-02-05 | Cisplatin + Radiotherapy | N | null | 240000005 | CISPLATIN + RT |
| 240000002 | 240000002 | 1.68 | 79 | Curative (C) | 2015-02-16 | 2015-02-24 | Cisplatin + Radiotherapy | 02 | null | 240000009 | CISPLATIN + RT |
| 240000003 | 240000002 | 1.61 | 109.3 | Adjuvant (A) | 2016-08-07 | 2016-08-21 | Cisplatin + Radiotherapy | 02 | N | 240000009 | CISPLATIN + RT |
| 240000004 | 240000003 | 1.7 | 77 | Curative (C) | 2015-12-09 | 2015-12-09 | CISPLATIN + RT | 1 | Y | 240000017 | CISPLATIN + RT |
| 240000005 | 240000003 | 1.6 | 89 | Curative (C) | 2018-02-10 | 2018-03-06 | Cisplatin + Radiotherapy | Y | Y | 240000017 | CISPLATIN + RT |
| 240000006 | 240012828 | 1.59 | null | Not known (9) | null | 2014-10-10 | Cisplatin + Radiotherapy | null | null | 240000026 | CISPLATIN + RT |
| 240000007 | 240000004 | 1.61 | null | null | 2014-06-23 | 2014-07-09 | Cisplatin + Radiotherapy | null | null | 240000030 | CISPLATIN + RT |
| 240000008 | 240000005 | 1.58 | 103.2 | Curative (C) | 2015-05-08 | 2015-05-08 | Cisplatin + Radiotherapy | N | Y | 240000032 | CISPLATIN + RT |
| 240000009 | 240000006 | null | 69.5 | Curative (C) | 2016-12-30 | 2017-01-27 | Cisplatin + Radiotherapy | N | null | 240000035 | CISPLATIN + RT |
| 240000010 | 240000007 | 1.65 | 132 | Curative (C) | 2017-10-11 | 2017-11-04 | Cisplatin + Radiotherapy | N | Y | 240000036 | CISPLATIN + RT |
| 240000011 | 240000007 | 1.43 | 66.1 | Curative (C) | 2015-07-15 | 2015-07-19 | Cisplatin + Radiotherapy | N | Y | 240000036 | CISPLATIN + RT |
| 240000012 | 240000007 | 1.59 | 67.8 | Curative (C) | 2015-02-05 | 2015-02-09 | Cisplatin + Radiotherapy | N | Y | 240000036 | CISPLATIN + RT |
| 240000013 | 240014604 | null | 95 | Adjuvant (A) | 2017-07-24 | 2017-08-16 | Cisplatin + Radiotherapy | N | Y | 240000043 | CISPLATIN + RT |
| 240000014 | 240015490 | 1.72 | null | Adjuvant (A) | 2016-02-27 | 2016-03-23 | Cisplatin + Radiotherapy | N | null | 240000046 | CISPLATIN + RT |
| 240000015 | 240000008 | null | 66.3 | Curative (C) | 2016-09-22 | 2016-11-02 | Cisplatin + Radiotherapy | N | Y | 240000047 | CISPLATIN + RT |
| 240000016 | 240000009 | 1.7 | 60 | Curative (C) | 2016-11-18 | 2016-11-23 | Cisplatin + Radiotherapy | 2 | Y | 240000048 | CISPLATIN + RT |
| 240000019 | 240014605 | 1.67 | 107 | Curative (C) | 2017-02-28 | 2017-03-27 | Cisplatin + Radiotherapy | N | Y | 240000052 | CISPLATIN + RT |
| 240000020 | 240000010 | 1.66 | 73.5 | Curative (C) | 2013-03-08 | 2013-03-30 | Cisplatin + Radiotherapy | 02 | Y | 240000056 | CISPLATIN + RT |
| 240000021 | 240000010 | 1.6 | 67.5 | Adjuvant (A) | 2015-03-23 | 2015-04-22 | Cisplatin + Radiotherapy | N | Y | 240000056 | CISPLATIN + RT |